Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.1K
3.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

2.6K
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global breast cancer survival estimates in 2017-2021 to advance the WHO Global Breast Cancer Initiative.

Nature medicine·2026
Same author

Mastectomy for Breast Cancer in Nigeria: A Mixed-Methods Study of Barriers, Facilitators, and Patient Attitudes.

Psycho-oncology·2026
Same author

Bridging gaps in breast cancer care: a Breast Cancer Care Quality Index to improve outcomes worldwide.

Ecancermedicalscience·2026
Same author

Lobular carcinoma and endocrine biology: Lessons learned and future directions.

Cancer·2025
Same author

Lessons from CONCORD and VENUSCANCER: closing global gaps in cancer care for women.

Lancet (London, England)·2025
Same author

The Australian Cancer Plan through a Caring Life Course Lens: Moving from Cancer to Care by Placing the Person at the Center of Care.

Seminars in oncology nursing·2025

Related Experiment Video

Updated: Apr 18, 2026

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.9K

Global cancer consortiums: moving from consensus to practice.

André M Ilbawi1, Benjamin O Anderson

  • 1Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA, amilbawi@mdanderson.org.

Annals of Surgical Oncology
|January 28, 2015
PubMed
Summary

Global cancer consortiums (GCCs) improve cancer care equity by developing evidence-based implementation strategies. These strategies, informed by implementation research, aim to translate expertise into tangible patient outcome improvements worldwide.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

932
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

6.0K

Related Experiment Videos

Last Updated: Apr 18, 2026

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.9K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

932
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

6.0K

Area of Science:

  • Global Health
  • Cancer Research
  • Health Equity

Background:

  • Cancer care disparities are severe in low-resource settings due to infrastructure deficits.
  • Global Cancer Consortiums (GCCs) aim to strengthen cancer care expertise and bridge the global cancer gap.
  • Cost-effective cancer interventions, including surgical services, are crucial for low- and medium-resource countries.

Purpose of the Study:

  • To highlight the role of GCCs in establishing consensus on best practice models for cancer service delivery.
  • To emphasize the need for evidence-based implementation strategies to improve patient outcomes.
  • To guide GCCs in translating clinical expertise into tangible improvements in patient care.

Main Methods:

  • Implementation research to inform consensus formation, program delivery, and outcome monitoring.
  • Adopting integrated, multisectoral plans with local involvement.
  • Defining shared implementation priorities through care pathways.
  • Building capacity via education, technology transfer, and outcome surveillance.
  • Promoting equity and balanced collaboration.

Main Results:

  • GCCs can bridge the gap between knowledge and practice in cancer care.
  • Implementation research is key to achieving GCC goals.
  • Successful implementation requires integrated planning, defined priorities, capacity building, and equitable collaboration.

Conclusions:

  • GCCs are vital for advancing cancer care globally, particularly in resource-limited settings.
  • Evidence-based implementation strategies are essential for programmatic success.
  • A collaborative, research-informed approach is necessary to achieve health equity in cancer care.